# Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache

> **NCT00778609** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 449 (actual)

## Conditions studied

- Oral Contraceptive
- Headache
- Pelvic Pain

## Interventions

- **DRUG:** EV/DNG (Qlaira, BAY86-5027)
- **DRUG:** Encapsulated Microgynon + Placebo

## Key facts

- **NCT ID:** NCT00778609
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 449 (ACTUAL)
- **Last updated:** 2016-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00778609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00778609, "Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT00778609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*